These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 18382211)
1. What do we know about anticoagulation in patients with heart failure? Ahnert AM; Freudenberger RS Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
3. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives]. Scardi S; Mazzone C Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal. Prom R; Usedom JE; Dull RB Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641 [TBL] [Abstract][Full Text] [Related]
5. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Dunkman WB; Johnson GR; Carson PE; Bhat G; Farrell L; Cohn JN Circulation; 1993 Jun; 87(6 Suppl):VI94-101. PubMed ID: 8500246 [TBL] [Abstract][Full Text] [Related]
8. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA; Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for heart failure: selecting the best therapy. Kohsaka S; Homma S Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1209-17. PubMed ID: 19814664 [TBL] [Abstract][Full Text] [Related]
10. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS; J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579 [TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction. Snowden S; Silus L Cardiol Rev; 2011; 19(1):36-40. PubMed ID: 21135601 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. Lip GY; Gibbs CR QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulation and heart failure. Graham SP Curr Cardiol Rep; 2001 Jan; 3(1):72-7. PubMed ID: 11139802 [TBL] [Abstract][Full Text] [Related]
14. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism]. Prati PL; Piazza V Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296 [TBL] [Abstract][Full Text] [Related]
15. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? Hermosillo AJ; Spinler SA Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet and anticoagulant therapy in patients with advanced heart failure. Lip GY; Chung I Thromb Res; 2005; 116(4):275-7. PubMed ID: 16038710 [No Abstract] [Full Text] [Related]